Quality of life in women with migraine: a systematic review
Views: 1250DOI:
https://doi.org/10.48208/HeadacheMed.2024.44Keywords:
Quality of life, Pain, Migraine in women, TreatmentAbstract
Introduction: Several chronic diseases interfere with quality of life (QoL), including migraine, especially in women who are the most affected. However, effective therapeutic interventions are capable of modifying the disease.
Objective: Our objective was to review the literature on QoL in women with migraine, before and after treatment.
Methods: This study was a systematic review of clinical trials on migraine in women and QoL published between November 2019 and October 2024. The research was carried out in the online database PubMed, using the descriptors “migraine in women” and “quality of life”.
Results: Eight articles were analyzed. They described 1,337 women with migraine aged 18 to 50 years. There was an improvement in QoL after therapeutic intervention, both drug and non-drug.
Conclusions: Women with migraine have their QoL impaired, but therapeutic interventions can modify the disease.
Downloads
References
Kluthcovsky ACGC, Takayanagui AMM. Qualidade de vida: aspectos conceituais. Revista Salus. 2007;1(1):13–15.
The WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–10. DOI: 10.1016/0277-9536(95)00112-k. DOI: https://doi.org/10.1016/0277-9536(95)00112-K
Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16(1):51–74. DOI: 10.1016/0891-4222(94)00028-8. DOI: https://doi.org/10.1016/0891-4222(94)00028-8
Sanvito WL, Monzillo, P.H. O livro das cefaleias. São Paulo: Atheneu, 2001.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. DOI: 10.1177/0333102417738202. DOI: https://doi.org/10.1177/0333102417738202
Queiroz LP, Peres MFP, Piovesan EJ, Kowacs F, Ciciarelli MC, Souza JA, et al. A nationwide population-based study of migraine in Brazil. Cephalalgia. 2009;29(6):642–9. DOI: 10.1111/j.1468-2982.2008.01782.x. DOI: https://doi.org/10.1111/j.1468-2982.2008.01782.x
Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z. Migraine is first cause of disability in under 50s: Will health politicians now take notice? J Headache Pain. 2018;19(1):17. DOI: 10.1186/s10194-018-0846-2. DOI: https://doi.org/10.1186/s10194-018-0846-2
MacGregor EA, Okonkwo R, Detke HC, Polavieja P, Fernandes MS, Pavlovic JM. Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: a post hoc analysis of EVOLVE-1 and EVOLVE-2. Headache. 2024;64(2):179–87. DOI: 10.1111/head.14652. DOI: https://doi.org/10.1111/head.14652
Arab A, Khorvash F, Kazemi M, Heidari Z, Askari G. Effects of the dietary approaches to stop hypertension (DASH) diet on clinical, quality of life and mental health outcomes in women with migraine: a randomized controlled trial. Br J Nutr. 2022;128(8):1535–44. DOI: 10.1017/S000711452100444X. DOI: https://doi.org/10.1017/S000711452100444X
Vajdi M, Khorvash F, Askari G. A randomized, double-blind, placebo-controlled parallel trial to test the effect of inulin supplementation on migraine headache characteristics, quality of life and mental health symptoms in women with migraine. Food Funct. 2024;15(19):10088–98. DOI: 10.1039/d4fo02796e. DOI: https://doi.org/10.1039/D4FO02796E
Babapour M, Khorvash F, Rouhani MH, Ghavami A, Ghasemi-Tehrani H, Heidari Z, et al. Effect of soy isoflavones supplementation on migraine characteristics, mental status and calcitonin gene-related peptide (CGRP) levels in women with migraine: results of randomized controlled trial. Nutr J. 2022;21(1):50. DOI: 10.1186/s12937-022-00802-z. DOI: https://doi.org/10.1186/s12937-022-00802-z
Celenay ST, Coban O, Mete O, Karahan N. An investigation of the effects of connective tissue massage in women with migraine: a controlled clinical trial. J Bodyw Mov Ther. 2023;33:112–9. DOI: 10.1016/j.jbmt.2022.09.008. DOI: https://doi.org/10.1016/j.jbmt.2022.09.008
Dzator JSA, Howe PRC, Coupland KG, Wong RHX. A randomized, double-blind, placebo-controlled crossover trial of resveratrol supplementation for prophylaxis of hormonal migraine. Nutrients. 2022;14(9):1763. DOI: 10.3390/nu14091763. DOI: https://doi.org/10.3390/nu14091763
Luo W, Cao X, Zhao J, Yang J, Cen Y, He J, et al. Health-related quality of life and associated factors in Chinese menstrual migraine patients: a cross-sectional study. BMC Womens Health. 2022;22(1):177. DOI: 10.1186/s12905-022-01760-8. DOI: https://doi.org/10.1186/s12905-022-01760-8
Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59. DOI. 10.1016/S0140-6736(17)32154-2.
Weatherall MW. The diagnosis and treatment of chronic migraine. Ther Adv Chronic Dis. 2015;6(3):115–23. DOI: 10.1177/2040622315579627. DOI: https://doi.org/10.1177/2040622315579627
Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache. 2021;61(1):60–8. DOI: 10.1111/head.14024. DOI: https://doi.org/10.1111/head.14024
Muñoz Gómez E, Aguilar Rodríguez M, Serra Añó P, Sempere Rubio N, Mollà Casanova S, Inglés M. Sex-related differences in migraine clinical features by frequency of occurrence: a cross-sectional study. Scand J Pain. 2023;23(3):553–62. DOI: 10.1515/sjpain-2022-0152. DOI: https://doi.org/10.1515/sjpain-2022-0152
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9. DOI. 10.1212/01.wnl.0000252808.97649.21. DOI: https://doi.org/10.1212/01.wnl.0000252808.97649.21
Agosti R. Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View. Headache. 2018:58 Suppl 1:17–32. DOI: 10.1111/head.13301. DOI: https://doi.org/10.1111/head.13301
Merikangas KR, Cui L, Richardson AK, Isler H, Khoromi S, Nakamura E, et al. Magnitude, impact, and stability of primary headache subtypes: 30-year prospective Swiss cohort study. BMJ. 2011:343:d5076. DOI: 10.1136/bmj.d5076. DOI: https://doi.org/10.1136/bmj.d5076
Ramsden CE, Zamora D, Faurot KR, Maclntosh B, Horowitz M, Keyes GS, et al. Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial. BMJ. 2021:374:n1448. DOI: 10.1136/bmj.n1448. DOI: https://doi.org/10.1136/bmj.n1448
Melhado EM, Santos PSF, Kaup AO, Costa ATNM, Roesler ACP, Piovesan EJ, et al. Consensus of the Brazilian Headache Society (SBCe) for the prophylactic treatment of episodic migraine: part I. Arq Neuropsiquiatr. 2022;80(8):845–61. DOI: 10.1055/s-0042-1756441. DOI: https://doi.org/10.1055/s-0042-1756441
Kowacs F, Roesler CAP, Piovesan EJ, Sarmento EM, Campos HC, Maciel Jr JA, et al. Consensus of the Brazilian Headache Society on the treatment of chronic migraine. Arq Neuropsiquiatr. 2019;77(7):509–20. DOI: 10.1590/0004-282X20190078. DOI: https://doi.org/10.1590/0004-282x20190078
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Adriana de Almeida Soares , Yasmine Maria Leódido Fortes, Wallyson Pablo de Oliveira Souza, Raimundo Pereira Silva-Néto (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
